Developed initially to store and transport temperature-sensitive Covid vaccines, the vessel can store many different types of vaccines and medical supplies. A prototype has been successfully trialled and the product is ready to be scaled up and supplied to the pharmaceutical industry.
The vessel is temperature-controlled using a process which efficiently distributes cold air throughout its compartments. It has live location and temperature tracking, allowing the distribution process to be monitored, and audited using a historic data log.
It has built-in vaccine protection with a self-closing lid and real-time condition LED indicators. Cross-vessel communication allows the units to share information and alert users to any problems.
Associate director at the MTC, Danny McGee said that using funding from the High Value Manufacturing Catapult, the product design team were quickly able to take the product from concept to reality.
"This product supports not only the ongoing pandemic, but also provides a solution for any temperature-critical transportable pharma goods. The product is a fine example of how innovation can have a direct and beneficial impact on society," he said.
MTC design engineer Harmail Sandhu said that in the
"Solving issues with vaccination distribution and storage was identified as the most impactful way the MTC could help in the fight against Covid-19. The hard work of the team has resulted in a successful outcome with the potential to make more vaccines available throughout the world by reducing wastage," he said.
The MTC was founded by the
The MTC aims to provide a competitive environment to bridge the gap between university-based research and the development of innovative manufacturing solutions, in line with the Government’s manufacturing strategy. The MTC is part of the High Value Manufacturing Catapult, supported by Innovate
More information on the vaccine project can be found at www.the-mtc.org/vaccinevessel